2024 OBIO Investment Summit Overview
Summit Highlights
Reverse pitches by licensing and business development professionals from corporate pharma & medtech at the Pharma and MedTech Business Development Forum, designed to connect Canadian life science companies with corporate venture professionals to explore partnerships and licensing opportunities.
Presentations from more than 90 of Canada’s most innovative companies bringing health science innovations in therapeutics, medical devices, diagnostics, digital health and health IT.
160 US and global venture capitalists (VC) and corporate VC investors.
Early Technology Showcase featuring the most promising technologies & projects with the greatest potential for commercialization and emerging health science companies from 9 of Canada’s leading research institutions and health organizations.
Presentations and discussions on cutting-edge topics, featuring leading industry voices addressing critical commercial, scientific, and market access issues.
600+ partnering meetings between investors, companies & ecosystem partners.
Links
“The early-stage life sciences companies at the OBIO® Investment Summit highlighted the vibrant nature and talent present in the Canadian community. The forum is exceptional with many companies aligned with our strategic offerings and several that brought what we consider to be industry-changing technology. What we have in the Canadian life sciences market is a true gem built on incredible talent, science, public funding and private partnerships, and Bayer is proud to be part of that ecosystem.”